The effect of different sulfonamides on phenytoin metabolism in man.
The effect of different sulfonamides on phenytoin metabolism in man.
复制标题
不同磺胺类药物对人体苯妥英代谢的影响。
DOI:
10.1111/j.0954-6820.1979.tb00729.x
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
L. Skovsted
中科院分区:
文献类型:
--
作者:
J. Hansen;J. Kampmann;K. Siersbaek;I. B. Lumholtz;M. Arrøé;U. Abildgaard;L. Skovsted
The influence on the metabolism of phenytoin of some sulfonamides given in common clinical doses has been studied. In single dose experiments sulfaphenazole increased phenytoin half-life (T/2) by 237% and decreased phenytoin metabolic clearance rate (MCR) by 67%. Sulfadiazine, sulfamethiazole, sulfamethoxazole + trimethoprim and trimethoprim increased phenytoin T/2 by 80, 66, 39 and 51% respectively, and decreased phenytoin MCR by 45, 36, 27 and 30% respectively. Sulfamethoxazole gave a small but significant increase in phenytoin T/2 but not a corresponding fall in phenytoin MCR. No changes were found in phenytoin T/2 and MCR after treatment with sulfamethoxypyridazine, sulfadimethoxine and sulfamethoxydiazine. Steady state experiments confirmed the findings of the single dose experiments. It is suggested that sulfaphenazole, sulfadiazine, sulfamethizole, sulfamethoxazole + trimethoprim and trimethoprim inhibit hepatic metabolism of phenytoin.